Prognostic value of troponin after elective percutaneous coronary intervention: A meta-analysis

✍ Scribed by Mark B. Nienhuis; Jan Paul Ottervanger; Henk J.G. Bilo; Bert D. Dikkeschei; Felix Zijlstra

• Publisher: John Wiley and Sons
• Year: 2008
• Tongue: English
• Weight: 105 KB
• Volume: 71
• Category: Article
• ISSN: 1522-1946
• DOI: 10.1002/ccd.21345

✦ Synopsis

Abstract

Background: Although the prognostic importance of troponin in patients with anacute coronary syndrome is clear, the significance of troponin elevation after elective percutaneous coronary intervention (PCI) is a subject of debate. However, most studies up to now had a small sample size and insufficient events during follow‐up. Methods: Electronic and manual searches were performed of studies reporting on prognosis of troponin after elective PCI. A meta‐analysis was done of all suitable studies, with death in follow‐up as primary endpoint and the combination of death or nonfatal myocardial infarction in follow‐up as secondary endpoint. Results: 20 studies involving 15,581 patients were included. These studies were published between 1998 and 2007. Overall, troponin was elevated after elective PCI in 32.9% of patients. The follow‐up period varied between 3 and 67 months (mean 16.3). Increased mortality was significantly associated with troponin elevation after PCI (4.4% vs. 3.3%, P = 0.001; OR 1.35). Furthermore, the combined endpoint of mortality or nonfatal myocardial infarction also occurred more often in patients with post‐procedural troponin elevation (8.1% vs. 5.2%, P < 0.001; OR 1.59). Conclusions: According to this meta‐analysis, troponin elevation after elective PCI provides important prognostic information. © 2008 Wiley‐Liss, Inc.